参考文献/References:
[1]Sung H,Ferlay J,Siegel RL,et al.Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J].CA Cancer J Clin,2021,71(3):209-249.[2]Sinicrope FA.Lynch Syndrome-Associated Colorectal Cancer[J].N Engl J Med,2018,379(8):764-773.[3]Carethers JM,Jung BH.Genetics and Genetic Biomarkers in Sporadic Colorectal Cancer[J].Gastroenterology,2015,149(5):1177-1190.[4]Hamid HKS,Emile SH,Davis GN.Prognostic Significance of Lymphocyte-to-Monocyte and Platelet-to-Lymphocyte Ratio in Rectal Cancer: A Systematic Review,Meta-analysis,and Meta-regression[J].Dis Colon Rectum,2022,65(2):178-187.[5]国家卫生健康委员会医政司,中华医学会肿瘤学分会.中国结直肠癌诊疗规范(2023版)[J].协和医学杂志,2023,14(4):706-733.[6]Hernandez-Ainsa M,Velamazan R,Lanas A,et al.Blood-Cell-Based Inflammatory Markers as a Useful Tool for Early Diagnosis in Colorectal Cancer[J].Front Med (Lausanne),2022,9:843074.[7]Atretkhany KN,Drutskaya MS,Nedospasov SA,et al.Chemokines,cytokines and exosomes help tumors to shape inflammatory microenvironment[J].Pharmacol Ther,2016,168:98-112.[8]Cools-Lartigue J,Spicer J,Mc Donald B,et al.Neutrophil extracellular traps sequester circulating tumor cells and promote metastasis[J].J Clin Invest,2013,123(8):3446-3458.[9]Okugawa Y,Toiyama Y,Yamamoto A,et al.Lymphocyte-C-reactive Protein Ratio as Promising New Marker for Predicting Surgical and Oncological Outcomes in Colorectal Cancer[J].Ann Surg,2020,272(2):342-351.[10]Del Prete M,Giampieri R,Loupakis F,et al.Prognostic clinical factors in pretreated colorectal cancer patients receiving regorafenib: implications for clinical management[J].Oncotarget,2015,6(32):33982-33992.[11]Chen JH,Zhai ET,Yuan YJ,et al.Systemic immune-inflammation index for predicting prognosis of colorectal cancer[J].World J Gastroenterol,2017,23(34):6261-6272.[12]王茜,王一菲,付海龙.术前 NLR、PLR结合 CEA表达水平与结直肠癌 TNM分期相关性分析[J].中国血液流变学杂志,2019,29(4):404-408.[13]唐阳,贾逸文,彭琼.血清和粪便CEA、CA199、AFP辅助诊断结直肠癌的研究[J].分子诊断与治疗杂志,2021,13(10):1665-1668.[14]郭宗全,李艳梅,陈新华.粪便 FCP与血清 CEA联合检测对大肠癌的诊断价值[J].山东医药,2019,59(31):83-85.[15]周婷,吴克俭.中性粒细胞/淋巴细胞、血小板/淋巴细胞和纤维蛋白原在结直肠癌中的预测作用[J].医学研究杂志,2019,48(8):154-157.[16]陈万臣,辛莘,郭雅丽,等.术前外周血NLR、PLR、RDW水平检测对结直肠癌早期诊断的应用价值[J].解放军医药杂志,2022,34(5):15-17.[17]李亚男,熊枝繁,周琦,等.外周血纤维蛋白原、血小板与淋巴细胞比值、癌胚抗原在老年结直肠癌中的预测作用研究[J].临床内科杂志,2022,39(9):602-606.[18]Zhan X,Sun X,Hong Y,et al.Combined Detection of Preoperative Neutrophil-to-Lymphocyte Ratio and CEA as an Independent Prognostic Factor in Nonmetastatic Patients Undergoing Colorectal Cancer Resection Is Superior to NLR or CEA Alone[J].Biomed Res Int,2017,2017:3809464.[19]Bhardwaj M,Weigl K,Tikk K,et al.Multiplex screening of 275 plasma protein biomarkers to identify a signature for early detection of colorectal cancer[J].Mol Oncol,2020,14(1):8-21.[20]Bayo Calero J,Casta?觡o López MA,Casado Monge PG,et al.Analysis of blood markers for early colorectal cancer diagnosis[J].J Gastrointest Oncol,2022,13(5):2259-2268.